Kevin Tang - 14 Dec 2023 Form 4 Insider Report for Rain Oncology Inc.

Role
10%+ Owner
Signature
Kevin Tang
Issuer symbol
N/A
Transactions as of
14 Dec 2023
Net transactions value
-$209,413
Form type
4
Filing time
18 Dec 2023, 18:29:00 UTC
Previous filing
13 Oct 2023
Next filing
02 Feb 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RAIN Common Stock Sale $29,531 -24,406 -0.61% $1.21 4,000,080 14 Dec 2023 By LP F1, F2
transaction RAIN Common Stock Sale $131,322 -109,435 -2.7% $1.20 3,890,645 15 Dec 2023 By LP F2, F3
transaction RAIN Common Stock Sale $48,560 -40,132 -1% $1.21 3,850,513 18 Dec 2023 By LP F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The prices reported are weighted-average prices. These shares were sold in multiple transactions at prices ranging from $1.20 to $1.22. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the SEC staff, upon request, all information regarding the number of shares sold at each price within the ranges set forth in Footnotes 1, 3 and 4.
F2 The shares are beneficially owned by Tang Capital Partners, LP ("TCP"). Kevin Tang is the sole manager of Tang Capital Management, LLC ("TCM"), which is the general partner of TCP. Mr. Tang has a pecuniary interest in the shares beneficially held by TCP.
F3 These shares were sold in multiple transactions ranging from $1.20 to $1.22.
F4 These shares were sold in multiple transactions ranging from $1.20 to $1.24.